Healthcare

  Stem Cell Assay Market accounted for US$ 1103.85 million in 2020 and is estimated to be US$ 6619.42 million by 2030 and is anticipated to register a CAGR of 19.8%. Stem cells are special human cells that are able to develop into many different cell types. This can range from muscle cells to brain cells. In some cases, they can also fix damaged tissues. Researchers believe that stem cell-based therapies may one day be used to treat serious illnesses such as paralysis and Alzheimer disease. The only stem cells now used to treat disease are hematopoietic stem cells. These are the blood cell-forming adult stem cells found in bone marrow. Every type of blood cell in the bone marrow starts as a stem cell. Stem cells are immature cells that are able to make other blood cells that mature and function as needed. The report "   Global Stem Cell Assay Market, By Type (Viability/Cytotoxicity, Isolation/Purification, Cell Identification, Proliferation, Cell Differentiation, Cell Function,

  Inulin is a group of naturally occurring polysaccharide and is indigestible carbohydrate belonging to a class of fructans. Inulin has obtained the GRAS (generally recognize as safe) status in United States, due to which it is highly used in pharmaceutical industries. It consists of rich fiber and has very low calories. Inulin plays an important role in the growth of intestinal bacteria due to which it is also considered as dietary fiber.   Inulin is used as probiotic, due to its health benefits, especially to lower sugar and fat levels. The Global Inulin Market accounted for US$ 1.33 billion in 2020 and is estimated to be US$ 2.29 billion by 2030 and is anticipated to register a CAGR of 5.5% The report  " Global Inulin Market,  By Application (Food and Beverage, Dietary Supplements, and Pharmaceutical)  and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030” . Increasing awareness about prebiot

  Pneumococcal Vaccine Market accounted for US$ US$8.1 billion in 2020 and is estimated to be US$ 13.5 billion by 2030 and is anticipated to register a CAGR of 5.3%. Serious and potentially fatal pneumococcal infections is protected by the pneumococcal vaccine. It's also known as the pneumonia vaccine. Pneumococcal infections caused by the bacterium Streptococcus pneumonia which lead to pneumonia, septicemia (a kind of blood poisoning) and meningitis.   All adults (65 years or older) should receive dose of pneumococcal polysaccharide vaccine (PPSV23). In addition, CDC recommends PCV13 based on shared clinical decision-making for adults 65 years or older who do not have an immune compromising condition, cerebrospinal fluid leak, or cochlear implant. The report "  Global Pneumococcal Vaccine Market, By Vaccine type (Pneumococcal Conjugate Vaccine and Pneumococcal Polysaccharide Vaccine), By Product Type (Prevnar 13, Synflorix, Pneumovax 23), By Sector (Public and Private), By